Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
about
Drug Development in Alzheimer's Disease: The Contribution of PET and SPECTNeuropharmacology and receptor studies in the elderly.Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.Putative amino acid transmitters in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.Alzheimer's disease: a correlative studyAlzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.Genetics of Psychosis in Alzheimer Disease.Alzheimer's disease: improvement of visual memory and visuoconstructive performance by treatment with picotesla range magnetic fields.Genetics of psychosis in Alzheimer's disease: a reviewDistribution of serotonin 5-HT1C receptor mRNA in adult rat brain.Effect of tetrahydroaminoacridine on cognition, function and behaviour in Alzheimer's disease.Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer diseaseToxicology of quinone-thioethers.Late-life depression: a neuropsychiatric approach.Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.Drugs to treat age-related neurodegenerative problems. The final frontier of medical science?Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy.Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status.Intrinsic Cholinergic Neurons in the Hippocampus: Fact or Artifact?Dopamine and serotonin systems in human and rodent brain: effects of age and neurodegenerative disease.Pharmacotherapy of cognitive impairment in Alzheimer's disease: a review.Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives.Neuroprotective Actions of Dietary Choline.Binding of the novel serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin in normal and Alzheimer brain.Comparative studies of the effects of RS-8359 and safrazine on monoamine oxidase in-vitro and in-vivo in mouse brain.Loss of calbindin-D28K from aging human cholinergic basal forebrain: relation to plaques and tangles.[Relations between specific neurochemical systems and memory: problems posed by dementia of the Alzheimer type]Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease.Alzheimer's disease: amino acid levels and brain metabolic status.Aging and regenerative capacity of the rat serotonergic system. A morphological, neurochemical and behavioral analysis after transplantation of fetal raphe cells.The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI study.Presynaptic serotonergic dysfunction in patients with Alzheimer's disease.Catecholamines and cognitive decline in aged nonhuman primates.Behavioral phenomenology in Alzheimer's disease, frontotemporal dementia, and late-life depression: a retrospective analysis.The evolution of Alzheimer's disease-related cytoskeletal pathology in the human raphe nuclei.Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.Molecular imaging of serotonin degeneration in mild cognitive impairment.Clinical studies of the cholinergic deficit in Alzheimer's disease. I. Neurochemical and neuroendocrine studies.Red blood cell abnormalities in Alzheimer disease.Aggressive behaviour in the elderly.
P2860
Q26749755-CA61DF97-E09A-4DD0-805A-7D52E16907E1Q30585270-ABDF5354-833D-46DB-8792-C42E94B60B7EQ33619754-BDA4CEFA-E12A-4931-B0FC-86D471D4D3DBQ33621061-69F3E67D-0FBB-41FB-B263-89B6E033B9F3Q33621991-C07D107B-EFDD-4DBA-B2BE-601BF31909DEQ33628651-2A232513-CEFB-4D82-99CE-35248922AF03Q33666458-63026F66-D8FE-45BC-BB91-5EC2966E2EA5Q34059778-F444CE61-3414-4E7F-BB46-62664B0BD65FQ34098861-834399D1-BAA4-4B66-BAB3-14E51F46E51FQ34524923-05B17B60-17AC-4FCD-80AF-E6B512BF10B0Q34578939-23E91C3A-D67F-4786-A771-D7971B4A15C4Q35626834-DCE65715-1B29-4731-B618-0A6FDA610CE5Q35662745-7DE4B192-E1D3-4C16-AFE2-FEDEC9D4915BQ36390860-97BC914F-1E13-4596-9077-719A5AF333BEQ36724965-6096E371-89C8-4F6A-A24D-4B23311332FCQ37591162-A030EDD3-03D4-4EA3-973B-EB129D871C6BQ37726596-40035035-16AF-4A54-910C-848E86380AAFQ38209851-2DE05691-87C6-4108-B28B-7C0D6E7D8F45Q38886038-E7D21166-96C5-4332-845B-B649AC3AAE5BQ39761733-591C3E3F-1C0F-4BEC-B462-1E2641913E03Q40552135-FEE741F4-6273-48E6-9A7A-869F092B5971Q40896821-FF6D9045-50FD-4DEF-82E4-1D2AEF00F70DQ41583852-B3F5C17B-E179-4F05-BABF-787674139019Q41763990-4DE2CA90-A715-497D-9741-113535AB8854Q42189902-3468878E-0776-496D-822D-9DD2FAA1F432Q42443940-304A31F5-551A-467B-83B7-D45602FF51AEQ42555682-E0C91583-50DF-4B2C-AF45-2B2D087340CEQ44060139-2CE59451-68DA-4F06-BB66-B123BC73E619Q44142866-E34BB5B5-A737-423B-88F0-6988191B42E1Q44394039-62E442C1-A3BF-4A5B-8D9A-E378FEDEBB65Q48106442-2914EFC3-02E9-4AFF-AACC-FE30C7A02F3CQ48263628-FF203E7D-95A8-41A7-BCB9-8FE5B5A70016Q48561024-4D1414A2-7237-4D27-893A-3FBF096F0E92Q48735328-1E1A29D4-FF5A-4AE9-8368-953F24AEBDDDQ49142219-6CEED981-642D-449D-B5D2-C57AFE957824Q49256155-217DB825-8EAC-4344-945F-B2BBEB613B92Q50583224-3ADDCAD7-F693-47FF-BEC5-0826AA3B2302Q53186368-2F676815-B9DC-46BC-87D3-4B3B0339C0B8Q53195791-E0292E1E-0437-429E-B7DF-4EBB504C495BQ54341494-1BA4D34C-987A-4C33-AD53-48C9DA914F39
P2860
Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Biochemical assessment of sero ...... trophy in Alzheimer's disease.
@en
Biochemical assessment of sero ...... trophy in Alzheimer's disease.
@nl
type
label
Biochemical assessment of sero ...... trophy in Alzheimer's disease.
@en
Biochemical assessment of sero ...... trophy in Alzheimer's disease.
@nl
prefLabel
Biochemical assessment of sero ...... trophy in Alzheimer's disease.
@en
Biochemical assessment of sero ...... trophy in Alzheimer's disease.
@nl
P2093
P1476
Biochemical assessment of sero ...... trophy in Alzheimer's disease.
@en
P2093
Davison AN
Goodhardt MJ
P304
P356
10.1111/J.1471-4159.1983.TB11838.X
P407
P577
1983-07-01T00:00:00Z